Lexology October 24, 2018
The newly enacted SUPPORT Act’s wide-ranging provisions take aim at the entire healthcare continuum, including providers, who will be on the front lines of change as the new law takes effect. The law includes amendments to Medicare and Medicaid, and changes affecting program integrity and transparency reporting of provider payments by drug and device manufacturers and the disposal of unused medication.
Earlier today, October 24, US President Donald Trump signed Congress’s long-anticipated response to the national opioid crisis into law. The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (HR 6)—a product of rare broad bipartisan support in both the House of Representatives (393-8) and the Senate (98-1)—is perhaps the most significant piece...